class,gene_id,Function description by WTD,gene_name,Description,fc,log2(fc),pval,qval,regulation,significant,GO,KEGG,KO_ENTRY,EntrezID,transcript_id,EC,trans_type,FPKM.HP6_1,FPKM.HP6_2,FPKM.Hp6_3,FPKM.HP6_5,FPKM.HP6_6,FPKM.HP0_1,FPKM.HP0_2,FPKM.HP0_4,FPKM.HP0_5,FPKM.HP0_6
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000053296,"Catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. This protein functions as a cellular oxygen sensor, and under normal oxygen concentration, modification by prolyl hydroxylation is a key regulatory event that targets HIF subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex",EGLN1,egl-9 family hypoxia inducible factor 1 ,2.51,1.33,0.00,0.00,up,yes,"GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0014069(postsynaptic density);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0031545(peptidyl-proline 4-dioxygenase activity);GO:0032364(oxygen homeostasis);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045765(regulation of angiogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0055008(cardiac muscle tissue morphogenesis);GO:0055114(oxidation-reduction process);GO:0060347(heart trabecula formation);GO:0060412(ventricular septum morphogenesis);GO:0060711(labyrinthine layer development);GO:0071731(response to nitric oxide);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:0099576(regulation of protein catabolic process at postsynapse, modulating synaptic transmission);GO:1901214(regulation of neuron death)",04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma),K09592,534075,ENSBTAT00000066920,EC:1.14.11.29,protein_coding,29.21,28.51,29.31,29.78,31.03,12.97,11.38,12.22,11.53,10.91
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000008172,Peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia.,EGLN3,egl-9 family hypoxia inducible factor 3 ,4.75,2.25,0,0,up,yes,"GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018126(protein hydroxylation);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0031545(peptidyl-proline 4-dioxygenase activity);GO:0042127(regulation of cell population proliferation);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)",04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma),K09592,535578,ENSBTAT00000010744,EC:1.14.11.29,protein_coding,131.17,130.70,142.22,146.84,140.16,28.33,29.16,29.89,29.51,28.61
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000012403,HIF-2/Arg1 axis confers an anti-inflammatory response,ARG1,arginase 1 ,382.79,8.58,0.01,0.07,up,yes,"GO:0000050(urea cycle);GO:0004053(arginase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006525(arginine metabolic process);GO:0016787(hydrolase activity);GO:0016813(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines);GO:0019547(arginine catabolic process to ornithine);GO:0030145(manganese ion binding);GO:0042130(negative regulation of T cell proliferation);GO:0042832(defense response to protozoan);GO:0046007(negative regulation of activated T cell proliferation);GO:0046872(metal ion binding);GO:0060336(negative regulation of interferon-gamma-mediated signaling pathway);GO:0070965(positive regulation of neutrophil mediated killing of fungus);GO:2000552(negative regulation of T-helper 2 cell cytokine production)",00220(Arginine biosynthesis);00330(Arginine and proline metabolism);05146(Amoebiasis),K01476,"513608,64129",ENSBTAT00000016461,EC:3.5.3.1,protein_coding,0.07,0,0.12,0,0,0,0,0,0,0
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000003741,"Ubiquitination, Ubiquitin ligase 3 mediate the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to specific substrate proteins",NEURL1,neuralized E3 ubiquitin protein ligase 1 ,673.62,9.40,0.00,0.00,up,yes,"GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006513(protein monoubiquitination);GO:0007288(sperm axoneme assembly);GO:0007399(nervous system development);GO:0007595(lactation);GO:0008285(negative regulation of cell population proliferation);GO:0014069(postsynaptic density);GO:0016567(protein ubiquitination);GO:0030317(flagellated sperm motility);GO:0043065(positive regulation of apoptotic process);GO:0043197(dendritic spine);GO:0043204(perikaryon);GO:0045183(translation factor activity, non-nucleic acid binding);GO:0045741(positive regulation of epidermal growth factor-activated receptor activity);GO:0045746(negative regulation of Notch signaling pathway);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0051491(positive regulation of filopodium assembly);GO:0060999(positive regulation of dendritic spine development);GO:0061630(ubiquitin protein ligase activity);GO:0071230(cellular response to amino acid stimulus);GO:0090129(positive regulation of synapse maturation);GO:0097440(apical dendrite)",NA,K01931,510334,ENSBTAT00000071563,EC:2.3.2.27,protein_coding,0.11,0.01,0.10,0.05,0.07,0,0,0,0,0
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000018948,a transcriptional regulator in adaptive response to low oxygen tension,HIF3A,hypoxia inducible factor 3 subunit alpha ,3.60,1.85,0.04,0.18,up,yes,"GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001666(response to hypoxia);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0046983(protein dimerization activity)",NA,K09096,507699,ENSBTAT00000077826;ENSBTAT00000077844,NA,protein_coding,0.02,0.05,0.03,0.05,0.03,0,0.02,0.01,0,0.02
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000016836,"Hypoxia, Glycolysis",PDK1,pyruvate dehydrogenase kinase 1 ,3.24,1.69,0.00,0.00,up,yes,GO:0004672(protein kinase activity);GO:0004740(pyruvate dehydrogenase (acetyl-transferring) kinase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005967(mitochondrial pyruvate dehydrogenase complex);GO:0006468(protein phosphorylation);GO:0008283(cell population proliferation);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0010906(regulation of glucose metabolic process);GO:0097411(hypoxia-inducible factor-1alpha signaling pathway);GO:0097411(hypoxia-inducible factor-1alpha signaling pathway),04066(HIF-1 signaling pathway);04360(Axon guidance);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer),K12077,"528655,5170",ENSBTAT00000084040;ENSBTAT00000038518,EC:2.7.11.2,protein_coding,11.76,11.73,11.27,11.99,11.89,4.02,3.35,3.24,4.33,3.18
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000017804,Regulates mitophagy during hypoxia,BNIP3,BCL2 interacting protein 3 ,9.45,3.24,0,0,up,yes,GO:0005635(nuclear envelope);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0005783(endoplasmic reticulum);GO:0006915(apoptotic process);GO:0008626(granzyme-mediated apoptotic signaling pathway);GO:0009617(response to bacterium);GO:0010637(negative regulation of mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016239(positive regulation of macroautophagy);GO:0031307(integral component of mitochondrial outer membrane);GO:0031966(mitochondrial membrane);GO:0035694(mitochondrial protein catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043068(positive regulation of programmed cell death);GO:0043243(positive regulation of protein complex disassembly);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045837(negative regulation of membrane potential);GO:0046902(regulation of mitochondrial membrane permeability);GO:0046982(protein heterodimerization activity);GO:0050873(brown fat cell differentiation);GO:0051020(GTPase binding);GO:0051607(defense response to virus);GO:0060548(negative regulation of cell death);GO:0071260(cellular response to mechanical stimulus);GO:0071279(cellular response to cobalt ion);GO:0071456(cellular response to hypoxia);GO:0072593(reactive oxygen species metabolic process);GO:0090141(positive regulation of mitochondrial fission);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097345(mitochondrial outer membrane permeabilization);GO:1901998(toxin transport);GO:1903715(regulation of aerobic respiration);GO:1990144(intrinsic apoptotic signaling pathway in response to hypoxia);GO:2000378(negative regulation of reactive oxygen species metabolic process),04068(FoxO signaling pathway);04137(Mitophagy - animal);04140(Autophagy - animal);05134(Legionellosis),K15464,615342,ENSBTAT00000023684,NA,protein_coding,277.13,301.05,327.98,330.32,342.44,30.60,30.76,35.97,36.68,32.98
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000021487,a negative regulatory component of the circadian clock in response to stress,CIART,circadian associated repressor of transcription ,14.02,3.81,0.00,0.00,up,yes,"GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0005634(nucleus);GO:0032922(circadian regulation of gene expression);GO:0045475(locomotor rhythm);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070888(E-box binding);GO:0070888(E-box binding)",NA,K21599,104968463,ENSBTAT00000028639;ENSBTAT00000076935,NA,protein_coding,1.28,1.05,1.67,0.91,1.62,0.06,0.07,0.14,0.14,0.06
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000009849,promotes the autophagic activity via mTOR signaling,PLAC8,placenta-specific 8 ,297.24,8.22,0.02,0.11,up,yes,NA,NA,NA,29124,ENSBTAT00000012987;ENSBTAT00000084285,NA,protein_coding,0,0,0,0.05,0.10,0,0,0,0,0
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000011970,nutrient sensing by regulating the AMPK-mTOR signaling pathway,FNIP2,folliculin interacting protein 2 ,2.08,1.05,0.00,0.00,up,yes,GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001932(regulation of protein phosphorylation);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007005(mitochondrion organization);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0031334(positive regulation of protein complex assembly);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0038202(TORC1 signaling);GO:0042030(ATPase inhibitor activity);GO:0051087(chaperone binding);GO:0051087(chaperone binding),04150(mTOR signaling pathway);04150(mTOR signaling pathway),K20401,100138353,ENSBTAT00000070927;ENSBTAT00000015882;ENSBTAT00000085360;ENSBTAT00000067422,NA,protein_coding,3.03,3.16,3.23,3.00,3.72,1.69,1.39,1.71,1.56,1.42
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000000163,"a negative regulator of mTOR, a serine/threonine kinase that regulates a variety of cellular functions such as growth, proliferation and autophagy",DDIT4,DNA damage inducible transcript 4 ,2.57,1.36,0,0,up,yes,GO:0001666(response to hypoxia);GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0007420(brain development);GO:0008283(cell population proliferation);GO:0009968(negative regulation of signal transduction);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0030182(neuron differentiation);GO:0032007(negative regulation of TOR signaling);GO:0032984(protein-containing complex disassembly);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0045820(negative regulation of glycolytic process);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0051607(defense response to virus);GO:0071549(cellular response to dexamethasone stimulus);GO:0071889(14-3-3 protein binding);GO:0072593(reactive oxygen species metabolic process);GO:1901216(positive regulation of neuron death);GO:1902532(negative regulation of intracellular signal transduction),04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);05206(MicroRNAs in cancer),K08270,529235,ENSBTAT00000000187,NA,protein_coding,179.47,194.72,192.31,195.75,193.01,73.34,77.90,73.58,73.50,73.69
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000010610,"a negative regulator of mTOR, a serine/threonine kinase that regulates a variety of cellular functions such as growth, proliferation and autophagy",DDIT4L,DNA damage inducible transcript 4 like ,2.00,1.00,0.00,0.00,up,yes,GO:0005737(cytoplasm);GO:0009968(negative regulation of signal transduction),NA,NA,510906,ENSBTAT00000014026,NA,protein_coding,1.02,0.61,0.57,0.89,0.79,0.50,0.44,0.26,0.45,0.29
Hypoxia-related responses (mitophagy/autophagy/stresses),ENSBTAG00000039035,heat shock protein 70,HSPA6,heat shock protein family A (Hsp70) member 6 ,3.76,1.91,0.00,0.00,up,yes,"GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005829(cytosol);GO:0006986(response to unfolded protein);GO:0008180(COP9 signalosome);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex);GO:0034605(cellular response to heat);GO:0034620(cellular response to unfolded protein);GO:0042026(protein refolding);GO:0042623(ATPase activity, coupled);GO:0044183(protein folding chaperone);GO:0051082(unfolded protein binding);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051787(misfolded protein binding)",NA,NA,539835,ENSBTAT00000057500,NA,protein_coding,1.07,1.11,0.84,1.20,1.09,0.25,0.41,0.26,0.22,0.28
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Glucose metabolism,ENSBTAG00000009617,"Glucose transport, GLUT1",SLC2A1,solute carrier family 2 member 1 ,3.80,1.927830692,0,0,up,yes,GO:0001939(female pronucleus);GO:0005215(transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008643(carbohydrate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0030496(midbody);GO:0030864(cortical actin cytoskeleton);GO:0031982(vesicle);GO:0033300(dehydroascorbic acid transmembrane transporter activity);GO:0042149(cellular response to glucose starvation);GO:0042470(melanosome);GO:0042802(identical protein binding);GO:0043621(protein self-association);GO:0045121(membrane raft);GO:0046323(glucose import);GO:0055056(D-glucose transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0065003(protein-containing complex assembly);GO:0070837(dehydroascorbic acid transport);GO:1904659(glucose transmembrane transport);GO:1904659(glucose transmembrane transport),04066(HIF-1 signaling pathway);04911(Insulin secretion);04919(Thyroid hormone signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04976(Bile secretion);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05211(Renal cell carcinoma);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer),K07299,282356,ENSBTAT00000042960;ENSBTAT00000068903,NA,protein_coding,288.6571788,302.0919833,326.0506884,334.6035572,349.2263255,85.9324549,83.15519323,82.64246317,85.89089663,83.06301202
Glucose metabolism,ENSBTAG00000004556,"Glucose transport, GLUT3",SLC2A3,solute carrier family 2 member 3 ,24.82,4.633677832,0,0,up,yes,GO:0005215(transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0008643(carbohydrate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:1904659(glucose transmembrane transport),NA,K08142,282358,ENSBTAT00000042889,NA,protein_coding,51.096714,55.116665,60.028595,59.308155,63.150681,2.313773,2.921848,2.179714,2.33714,1.877318
Glucose metabolism,ENSBTAG00000013108,Glycolysis,HK2,hexokinase 2 ,3.01,1.59,0,0,up,yes,"GO:0000166(nucleotide binding);GO:0001678(cellular glucose homeostasis);GO:0004340(glucokinase activity);GO:0004396(hexokinase activity);GO:0005524(ATP binding);GO:0005536(glucose binding);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006096(glycolytic process);GO:0008637(apoptotic mitochondrial changes);GO:0008865(fructokinase activity);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0019158(mannokinase activity);GO:0035795(negative regulation of mitochondrial membrane permeability);GO:0045766(positive regulation of angiogenesis);GO:0046324(regulation of glucose import);GO:0046835(carbohydrate phosphorylation);GO:0051156(glucose 6-phosphate metabolic process);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:1904925(positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process)","00010(Glycolysis / Gluconeogenesis);00051(Fructose and mannose metabolism);00052(Galactose metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism);00524(Neomycin, kanamycin and gentamicin biosynthesis);04066(HIF-1 signaling pathway);04910(Insulin signaling pathway);04930(Type II diabetes mellitus);04973(Carbohydrate digestion and absorption);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer)",K00844,"788926,29911,3741,3796",ENSBTAT00000060994;ENSBTAT00000079050,EC:2.7.1.1,protein_coding,85.73,85.68,94.22,94.47,95.75,30.90,29.55,29.84,31.97,28.93
Glucose metabolism,ENSBTAG00000008401,Glycolysis,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 ",8.77,3.13,0,0,up,yes,"GO:0003824(catalytic activity);GO:0003873(6-phosphofructo-2-kinase activity);GO:0004331(fructose-2,6-bisphosphate 2-phosphatase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016311(dephosphorylation);GO:0046835(carbohydrate phosphorylation);GO:0046835(carbohydrate phosphorylation)",00051(Fructose and mannose metabolism);04066(HIF-1 signaling pathway);04152(AMPK signaling pathway);04152(AMPK signaling pathway),K01103,407183,ENSBTAT00000078427;ENSBTAT00000057357;ENSBTAT00000082281;ENSBTAT00000074484;ENSBTAT00000077870;ENSBTAT00000067683,3.1.3.46;EC:2.7.1.105,protein_coding,11.96,13.27,13.64,14.33,15.31,1.41,1.63,1.85,1.36,1.57
Glucose metabolism,ENSBTAG00000017461,"Glycolysis, lactate transport, ",SLC16A3,solute carrier family 16 member 3 ,4.95,2.308833596,2.1729E-225,2.3156E-222,up,yes,GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0035873(lactate transmembrane transport);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport),05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer),K08180,510085,ENSBTAT00000023209;ENSBTAT00000066453,NA,protein_coding,28.90508016,33.43219505,35.79905217,34.40618779,36.62424412,6.869963211,5.817419327,7.505964922,7.383127986,6.565359801
Glucose metabolism,ENSBTAG00000016836,"Hypoxia, Glycolysis",PDK1,pyruvate dehydrogenase kinase 1 ,3.24,1.69,0.00,0.00,up,yes,GO:0004672(protein kinase activity);GO:0004740(pyruvate dehydrogenase (acetyl-transferring) kinase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005967(mitochondrial pyruvate dehydrogenase complex);GO:0006468(protein phosphorylation);GO:0008283(cell population proliferation);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0010906(regulation of glucose metabolic process);GO:0097411(hypoxia-inducible factor-1alpha signaling pathway);GO:0097411(hypoxia-inducible factor-1alpha signaling pathway),04066(HIF-1 signaling pathway);04360(Axon guidance);05230(Central carbon metabolism in cancer);05230(Central carbon metabolism in cancer),K12077,"528655,5170",ENSBTAT00000084040;ENSBTAT00000038518,EC:2.7.11.2,protein_coding,11.76,11.73,11.27,11.99,11.89,4.02,3.35,3.24,4.33,3.18
Glucose metabolism,ENSBTAG00000031503,"ETC, OXPHOS",NDUFA4L2,"NDUFA4, mitochondrial complex associated like 2 ",12.52,3.65,0.00,0.00,up,yes,GO:0004129(cytochrome-c oxidase activity);GO:0005751(mitochondrial respiratory chain complex IV);GO:0022900(electron transport chain);GO:1902600(proton transmembrane transport),00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease),K03948,613541,ENSBTAT00000038247,NA,protein_coding,5.15,5.48,5.71,5.91,6.57,0.88,0.55,0.19,0.36,0.33
Glucose metabolism,ENSBTAG00000014831,glycogen biosynthesis,PPP1R3C,protein phosphatase 1 regulatory subunit 3C ,6.66,2.74,0.00,0.00,up,yes,GO:0005515(protein binding);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0005978(glycogen biosynthetic process);GO:0019888(protein phosphatase regulator activity);GO:0019903(protein phosphatase binding);GO:0043666(regulation of phosphoprotein phosphatase activity),04910(Insulin signaling pathway);04931(Insulin resistance),K07189,539466,ENSBTAT00000019753,NA,protein_coding,4.13,3.59,4.05,4.40,4.45,0.48,0.69,0.67,0.42,0.84
Glucose metabolism,ENSBTAG00000054777,glycogen biosynthesis,PPP1R3G,protein phosphatase 1 regulatory subunit 3G ,1935.74,10.92,0.00,0.00,up,yes,GO:0005515(protein binding),NA,NA,616147,ENSBTAT00000084835,NA,protein_coding,0.11,0.36,0.12,0.25,0.13,0,0,0,0,0
Glucose metabolism,ENSBTAG00000031814,"gluconeogenesis, provide pyruvate for gluconeogenesis to form glucose from serine.",SDS,serine dehydratase ,17.64,4.14,0.00,0.01,up,yes,GO:0003941(L-serine ammonia-lyase activity);GO:0004794(L-threonine ammonia-lyase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006520(cellular amino acid metabolic process);GO:0006565(L-serine catabolic process);GO:0006567(threonine catabolic process);GO:0030170(pyridoxal phosphate binding);GO:0042803(protein homodimerization activity);GO:0042866(pyruvate biosynthetic process),"00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism);00290(Valine, leucine and isoleucine biosynthesis)",K17989,"514346,51119",ENSBTAT00000081738,4.3.1.19;EC:4.3.1.17,protein_coding,0.45,0.53,0.20,0.32,0.47,0.07,0,0.04,0,0
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lipid metabolism,ENSBTAG00000010236,Lipid droplet size,CIDEB,cell death inducing DFFA like effector b ,4.18,2.06,0.00,0.03,up,yes,GO:0005622(intracellular);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0010942(positive regulation of cell death);GO:0042802(identical protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097194(execution phase of apoptosis);GO:0097202(activation of cysteine-type endopeptidase activity);GO:0097202(activation of cysteine-type endopeptidase activity),NA,NA,528834,ENSBTAT00000013524;ENSBTAT00000085235,NA,protein_coding,0.08,0.26,0.14,0.32,0.17,0,0.01,0.07,0.09,0.06
Lipid metabolism,ENSBTAG00000010507,transports carnitine,SLC22A16,solute carrier family 22 member 16 ,0.41,-1.28,0.00,0.01,down,yes,GO:0005275(amine transmembrane transporter activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007275(multicellular organism development);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0015101(organic cation transmembrane transporter activity);GO:0015226(carnitine transmembrane transporter activity);GO:0015695(organic cation transport);GO:0015879(carnitine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030154(cell differentiation);GO:0030317(flagellated sperm motility);GO:0046717(acid secretion);GO:0055085(transmembrane transport),NA,K08212,614380,ENSBTAT00000028664,NA,protein_coding,0.27,0.12,0.16,0.11,0.12,0.27,0.45,0.35,0.36,0.47
Lipid metabolism,ENSBTAG00000009965,Lipid beta-oxidation,ECI1,enoyl-CoA delta isomerase 1 ,2.21,1.15,0.00,0.00,up,yes,GO:0003824(catalytic activity);GO:0004165(dodecenoyl-CoA delta-isomerase activity);GO:0004300(enoyl-CoA hydratase activity);GO:0005739(mitochondrion);GO:0006635(fatty acid beta-oxidation);GO:0016853(isomerase activity),00071(Fatty acid degradation),K13238,535174,ENSBTAT00000013144,EC:5.3.3.8,protein_coding,19.09,19.59,21.60,20.97,21.75,9.56,9.68,8.79,9.60,8.93
Lipid metabolism,ENSBTAG00000017242,Polyunsaturated fatty acid synthesis,FADS6,fatty acid desaturase 6 ,2.27,1.18,0.00,0.00,up,yes,GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process),NA,K12419,"523867,3992",ENSBTAT00000022906,EC:1.14.19.-,protein_coding,1.62,1.34,1.27,1.44,1.30,0.71,0.54,0.74,0.57,0.51
Lipid metabolism,ENSBTAG00000012222,2-hydroxysphingolipids synthesis ,FA2H,fatty acid 2-hydroxylase ,2.58,1.37,0.01,0.05,up,yes,GO:0001949(sebaceous gland cell differentiation);GO:0005506(iron ion binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006679(glucosylceramide biosynthetic process);GO:0006682(galactosylceramide biosynthetic process);GO:0008610(lipid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0030258(lipid modification);GO:0032286(central nervous system myelin maintenance);GO:0032287(peripheral nervous system myelin maintenance);GO:0042127(regulation of cell population proliferation);GO:0042634(regulation of hair cycle);GO:0044857(plasma membrane raft organization);GO:0046513(ceramide biosynthetic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0061436(establishment of skin barrier);GO:0080132(fatty acid alpha-hydroxylase activity),NA,K19703,516891,ENSBTAT00000016212,EC:1.14.18.6,protein_coding,0.25,0.35,0.13,0.32,0.15,0.05,0.17,0.02,0.09,0.12
Lipid metabolism,ENSBTAG00000018517,VLDL,VLDLR,very low density lipoprotein receptor ,2.10,1.07,0.00,0.00,up,yes,GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021517(ventral spinal cord development);GO:0030229(very-low-density lipoprotein particle receptor activity);GO:0034185(apolipoprotein binding);GO:0034189(very-low-density lipoprotein particle binding);GO:0034436(glycoprotein transport);GO:0034437(glycoprotein transporter activity);GO:0034447(very-low-density lipoprotein particle clearance);GO:0038025(reelin receptor activity);GO:0038026(reelin-mediated signaling pathway);GO:0043235(receptor complex);GO:0045860(positive regulation of protein kinase activity);GO:0048306(calcium-dependent protein binding);GO:0048813(dendrite morphogenesis);GO:1900006(positive regulation of dendrite development);GO:1900006(positive regulation of dendrite development),NA,K20053,282123,ENSBTAT00000083030;ENSBTAT00000067046;ENSBTAT00000068334;ENSBTAT00000071362,NA,protein_coding,13.99,13.38,14.43,14.90,15.13,7.39,6.69,6.08,7.38,6.70
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Hormones/Grow factors,ENSBTAG00000030343,Growth factor,FGF23,fibroblast growth factor 23 ,1917.18,10.90,0.00,0.00,up,yes,"GO:0000165(MAPK cascade);GO:0005104(fibroblast growth factor receptor binding);GO:0005105(type 1 fibroblast growth factor receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005623(cell);GO:0008083(growth factor activity);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010469(regulation of signaling receptor activity);GO:0010966(regulation of phosphate transport);GO:0010980(positive regulation of vitamin D 24-hydroxylase activity);GO:0030500(regulation of bone mineralization);GO:0030502(negative regulation of bone mineralization);GO:0030643(cellular phosphate ion homeostasis);GO:0042369(vitamin D catabolic process);GO:0045668(negative regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0055062(phosphate ion homeostasis);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090080(positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04810(Regulation of actin cytoskeleton);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05218(Melanoma);05224(Breast cancer);05226(Gastric cancer)",K22428,530239,ENSBTAT00000008940,NA,protein_coding,0.21,0.17,0.04,0.32,0.22,0,0,0,0,0
Hormones/Grow factors,ENSBTAG00000011624,Growth factor,FGF21,fibroblast growth factor 21 ,0.18,-2.48,0.00,0.01,down,yes,GO:0005104(fibroblast growth factor receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010469(regulation of signaling receptor activity);GO:0032094(response to food);GO:0046326(positive regulation of glucose import);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090080(positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway);GO:0120162(positive regulation of cold-induced thermogenesis),04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04714(Thermogenesis);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer);05218(Melanoma);05224(Breast cancer);05226(Gastric cancer),K22429,785576,ENSBTAT00000015438,NA,protein_coding,0,0.50,0.18,0.66,0.27,1.53,1.58,1.97,2.16,1.73
Hormones/Grow factors,ENSBTAG00000014078,Growth factor,IGFBPL1,insulin like growth factor binding protein like 1 ,0.00,-8.11,0.01,0.07,down,yes,GO:0001558(regulation of cell growth);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0071228(cellular response to tumor cell),NA,NA,616886,ENSBTAT00000018719,NA,protein_coding,0,0,0,0,0,0.01,0.02,0.11,0,0
Hormones/Grow factors,ENSBTAG00000019772,oxytocin,OXTR,oxytocin receptor ,3.77,1.92,0.00,0.00,up,yes,GO:0001992(regulation of systemic arterial blood pressure by vasopressin);GO:0004930(G protein-coupled receptor activity);GO:0004990(oxytocin receptor activity);GO:0005000(vasopressin receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007565(female pregnancy);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032870(cellular response to hormone stimulus);GO:0035176(social behavior);GO:0042711(maternal behavior);GO:0045777(positive regulation of blood pressure);GO:0045907(positive regulation of vasoconstriction);GO:0120162(positive regulation of cold-induced thermogenesis),04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04921(Oxytocin signaling pathway),K04229,281371,ENSBTAT00000026346,NA,protein_coding,3.87,4.22,3.53,4.76,4.33,1.64,1.15,0.74,1.01,0.94
Hormones/Grow factors,ENSBTAG00000024648,Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.,PGR,progesterone receptor ,0.42,-1.24,0.05,0.20,down,yes,"GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001542(ovulation from ovarian follicle);GO:0002070(epithelial cell maturation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005496(steroid binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0010629(negative regulation of gene expression);GO:0019899(enzyme binding);GO:0030879(mammary gland development);GO:0038001(paracrine signaling);GO:0042802(identical protein binding);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048286(lung alveolus development);GO:0050678(regulation of epithelial cell proliferation);GO:0050847(progesterone receptor signaling pathway);GO:0051117(ATPase binding);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis)",04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);05224(Breast cancer),K08556,100848466,ENSBTAT00000010545,NA,protein_coding,0.05,0.05,0.02,0.09,0.06,0.07,0.14,0.12,0.24,0.05
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Protein synthesis/modifications,ENSBTAG00000013070,transcription elongation,EAF2,ELL associated factor 2 ,670.28,9.39,0.02,0.10,up,yes,"GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008023(transcription elongation factor complex);GO:0030308(negative regulation of cell growth);GO:0032783(ELL-EAF complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development)",NA,K15186,"613523,55929",ENSBTAT00000017380,NA,protein_coding,0.26,0.07,0,0,0,0,0,0,0,0
Protein synthesis/modifications,ENSBTAG00000038865,transcription elongation,TCEA3,transcription elongation factor A3 ,2.51,1.33,0.01,0.08,up,yes,"GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0046872(metal ion binding)",NA,NA,533803,ENSBTAT00000072833;ENSBTAT00000004501,NA,protein_coding,0.07,0.16,0.10,0.19,0.28,0.05,0.04,0.05,0.09,0.09
Protein synthesis/modifications,ENSBTAG00000015716,Involved in chaperone cofactor-dependent protein refolding,ERO1A,endoplasmic reticulum oxidoreductase 1 alpha ,3.56,1.83,0,0,up,yes,"GO:0003756(protein disulfide isomerase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006457(protein folding);GO:0006915(apoptotic process);GO:0015035(protein disulfide oxidoreductase activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016671(oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor);GO:0019471(4-hydroxyproline metabolic process);GO:0022417(protein maturation by protein folding);GO:0030198(extracellular matrix organization);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0034975(protein folding in endoplasmic reticulum);GO:0034976(response to endoplasmic reticulum stress);GO:0045454(cell redox homeostasis);GO:0050873(brown fat cell differentiation);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055114(oxidation-reduction process);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress)",04141(Protein processing in endoplasmic reticulum);04141(Protein processing in endoplasmic reticulum),K10950,100125317,ENSBTAT00000020878;ENSBTAT00000079359;ENSBTAT00000079822,EC:1.8.4.-,protein_coding,53.64,60.37,62.25,60.88,60.19,16.74,15.87,16.53,17.59,16.73
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Signaling,ENSBTAG00000006894,catalyzing the production of nitric oxide (NO) from L-arginine,NOS2,nitric oxide synthase 2 ,8.63,3.11,0.00,0.00,up,yes,GO:0001666(response to hypoxia);GO:0003958(NADPH-hemoprotein reductase activity);GO:0004517(nitric-oxide synthase activity);GO:0005102(signaling receptor binding);GO:0005516(calmodulin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006527(arginine catabolic process);GO:0006801(superoxide metabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0007263(nitric oxide mediated signal transduction);GO:0007623(circadian rhythm);GO:0009617(response to bacterium);GO:0009725(response to hormone);GO:0010181(FMN binding);GO:0010629(negative regulation of gene expression);GO:0012506(vesicle membrane);GO:0016491(oxidoreductase activity);GO:0018119(peptidyl-cysteine S-nitrosylation);GO:0020037(heme binding);GO:0030863(cortical cytoskeleton);GO:0031284(positive regulation of guanylate cyclase activity);GO:0032310(prostaglandin secretion);GO:0032496(response to lipopolysaccharide);GO:0034617(tetrahydrobiopterin binding);GO:0034618(arginine binding);GO:0035690(cellular response to drug);GO:0042127(regulation of cell population proliferation);GO:0042177(negative regulation of protein catabolic process);GO:0042742(defense response to bacterium);GO:0042803(protein homodimerization activity);GO:0045776(negative regulation of blood pressure);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0050796(regulation of insulin secretion);GO:0051712(positive regulation of killing of cells of other organism);GO:0055114(oxidation-reduction process);GO:0071222(cellular response to lipopolysaccharide);GO:0071346(cellular response to interferon-gamma);GO:0072604(interleukin-6 secretion);GO:0072606(interleukin-8 secretion);GO:1900015(regulation of cytokine production involved in inflammatory response);GO:1900015(regulation of cytokine production involved in inflammatory response),00220(Arginine biosynthesis);00330(Arginine and proline metabolism);04020(Calcium signaling pathway);04066(HIF-1 signaling pathway);04146(Peroxisome);04371(Apelin signaling pathway);04926(Relaxin signaling pathway);05132(Salmonella infection);05133(Pertussis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05200(Pathways in cancer);05222(Small cell lung cancer);05222(Small cell lung cancer),K13241,"282876,339345",ENSBTAT00000009062;ENSBTAT00000085225,EC:1.14.13.39,protein_coding,4.23,4.34,5.45,4.91,4.32,0.56,0.54,0.54,0.66,0.40
Signaling,ENSBTAG00000020049,Modulates calcium-dependent activity ,CABP1,calcium binding protein 1 ,1901.37,10.89,0.00,0.00,up,yes,GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0007601(visual perception);GO:0008139(nuclear localization sequence binding);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030054(cell junction);GO:0042308(negative regulation of protein import into nucleus);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050896(response to stimulus);GO:0050896(response to stimulus),NA,NA,"281653,795",ENSBTAT00000084965;ENSBTAT00000083615;ENSBTAT00000026714,NA,protein_coding,0.10,0.18,0.20,0.34,0.12,0,0,0,0,0
Signaling,ENSBTAG00000006870,Ras protein signal transduction,RASGEF1A,RasGEF domain family member 1A ,3.22,1.69,0.00,0.00,up,yes,GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0007264(small GTPase mediated signal transduction);GO:0016477(cell migration);GO:0046579(positive regulation of Ras protein signal transduction);GO:0046579(positive regulation of Ras protein signal transduction),NA,NA,514877,ENSBTAT00000076538;ENSBTAT00000009038;ENSBTAT00000084300,NA,protein_coding,1.36,1.05,1.32,1.42,1.31,0.30,0.48,0.49,0.35,0.39
Signaling,ENSBTAG00000055156,Ras protein signal transduction,RASGEF1C,RasGEF domain family member 1C ,248.00,7.95,0.05,0.20,up,yes,GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0007264(small GTPase mediated signal transduction),NA,NA,523107,ENSBTAT00000071554,NA,protein_coding,0.09,0,0.03,0,0,0,0,0,0,0
Signaling,ENSBTAG00000021525,enable GDP binding activity,RAB42,"RAB42, member RAS oncogene family ",1621.11,10.66,0.00,0.02,up,yes,GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005623(cell);GO:0006886(intracellular protein transport);GO:0032482(Rab protein signal transduction),NA,K07929,"514286,646996",ENSBTAT00000028686,NA,protein_coding,0,0.43,0.22,0.16,0,0,0,0,0,0
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Cell structure/proliferation,ENSBTAG00000010229,interact with receptors anchored in the plasma membrane of cells adjacent to basement membranes,LAMA2,laminin subunit alpha 2 ,96.18,6.59,0.04,0.19,up,yes,GO:0005102(signaling receptor binding);GO:0007155(cell adhesion);GO:0030155(regulation of cell adhesion);GO:0030334(regulation of cell migration);GO:0045995(regulation of embryonic development),NA,NA,100138434,ENSBTAT00000073403,NA,protein_coding,0,0,0,0.03,0.01,0,0,0,0,0
Cell structure/proliferation,ENSBTAG00000016627,regulating the actin cytoskeleton required for membrane ruffling.,WASF1,WAS protein family member 1 ,342.35,8.42,0.00,0.01,up,yes,GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0006898(receptor-mediated endocytosis);GO:0016601(Rac protein signal transduction);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0031175(neuron projection development);GO:0031209(SCAR complex);GO:0032154(cleavage furrow);GO:0032991(protein-containing complex);GO:0034237(protein kinase A regulatory subunit binding);GO:0035046(pronuclear migration);GO:0045120(pronucleus);GO:0045202(synapse);GO:0048365(Rac GTPase binding);GO:0051018(protein kinase A binding);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0071933(Arp2/3 complex binding);GO:0072673(lamellipodium morphogenesis);GO:0097484(dendrite extension);GO:0098794(postsynapse);GO:0098885(modification of postsynaptic actin cytoskeleton);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation),04520(Adherens junction);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05132(Salmonella infection);05231(Choline metabolism in cancer),K05753,531488,ENSBTAT00000022116,NA,protein_coding,0.06,0.09,0.01,0,0.01,0,0,0,0,0
Cell structure/proliferation,ENSBTAG00000020939,cell proliferation and motility,PLAC9,placenta specific 9 ,0.05,-4.41,0.01,0.06,down,yes,GO:0005576(extracellular region),NA,NA,510496,ENSBTAT00000027890,NA,protein_coding,0.03,0,0,0,0,0.12,0.45,0.09,0,0
,,,,,,,,,,,,,,,,,,,,,,,,,,,
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Others,ENSBTAG00000005339,induces blood vessels ,VEGFA,vascular endothelial growth factor A ,2.88,1.53,0.00,0.00,up,yes,GO:0001525(angiogenesis);GO:0001666(response to hypoxia);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001968(fibronectin binding);GO:0002040(sprouting angiogenesis);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0002092(positive regulation of receptor internalization);GO:0005125(cytokine activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005172(vascular endothelial growth factor receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0010595(positive regulation of endothelial cell migration);GO:0016020(membrane);GO:0030141(secretory granule);GO:0030154(cell differentiation);GO:0030224(monocyte differentiation);GO:0030225(macrophage differentiation);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031334(positive regulation of protein complex assembly);GO:0031954(positive regulation of protein autophosphorylation);GO:0032147(activation of protein kinase activity);GO:0032793(positive regulation of CREB transcription factor activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035148(tube formation);GO:0035767(endothelial cell chemotaxis);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0038033(positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0038091(positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway);GO:0042056(chemoattractant activity);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043183(vascular endothelial growth factor receptor 1 binding);GO:0043184(vascular endothelial growth factor receptor 2 binding);GO:0043406(positive regulation of MAP kinase activity);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0045785(positive regulation of cell adhesion);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048018(receptor ligand activity);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050918(positive chemotaxis);GO:0050927(positive regulation of positive chemotaxis);GO:0050930(induction of positive chemotaxis);GO:0051272(positive regulation of cellular component movement);GO:0051781(positive regulation of cell division);GO:0051894(positive regulation of focal adhesion assembly);GO:0060754(positive regulation of mast cell chemotaxis);GO:0071456(cellular response to hypoxia);GO:0090037(positive regulation of protein kinase C signaling);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0097475(motor neuron migration);GO:1900086(positive regulation of peptidyl-tyrosine autophosphorylation);GO:1903572(positive regulation of protein kinase D signaling);GO:1903572(positive regulation of protein kinase D signaling),01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04370(VEGF signaling pathway);04510(Focal adhesion);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05219(Bladder cancer);05323(Rheumatoid arthritis);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis),K05448,281572,ENSBTAT00000046700;ENSBTAT00000007026;ENSBTAT00000065013;ENSBTAT00000065271,NA,protein_coding,124.21,127.93,132.54,139.65,141.89,45.17,42.35,46.71,48.68,48.46
Others,ENSBTAG00000021775,bicarbonate transport; regulation of intracellular Ph,SLC4A9,solute carrier family 4 member 9 ,227.67,7.83080039,0.025839137,0.131172713,up,yes,GO:0005452(inorganic anion exchanger activity);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006820(anion transport);GO:0008509(anion transmembrane transporter activity);GO:0008510(sodium:bicarbonate symporter activity);GO:0015698(inorganic anion transport);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051453(regulation of intracellular pH);GO:0098656(anion transmembrane transport),NA,K13860,509031,ENSBTAT00000029024,NA,protein_coding,0.032536,0.081299,0,0,0,0,0,0,0,0
Others,ENSBTAG00000000910, L-proline transporter,SLC6A7,solute carrier family 6 member 7 ,4.62,2.20642118,0.040647138,0.18155922,up,yes,GO:0005328(neurotransmitter:sodium symporter activity);GO:0005886(plasma membrane);GO:0006836(neurotransmitter transport);GO:0015193(L-proline transmembrane transporter activity);GO:0015293(symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035524(proline transmembrane transport),04721(Synaptic vesicle cycle),K05040,539786,ENSBTAT00000035184,NA,protein_coding,0.127133,0.067742,0.037813,0,0.058786,0.01116,0.012155,0.039839,0,0
Others,ENSBTAG00000004386,Immune responses,SOCS1,suppressor of cytokine signaling 1 ,5.98,2.58,0.01,0.06,up,yes,"GO:0001932(regulation of protein phosphorylation);GO:0005159(insulin-like growth factor receptor binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0010533(regulation of activation of Janus kinase activity);GO:0016567(protein ubiquitination);GO:0019210(kinase inhibitor activity);GO:0019221(cytokine-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0033673(negative regulation of kinase activity);GO:0035556(intracellular signal transduction);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042509(regulation of tyrosine phosphorylation of STAT protein);GO:0042532(negative regulation of tyrosine phosphorylation of STAT protein);GO:0043372(positive regulation of CD4-positive, alpha-beta T cell differentiation);GO:0043377(negative regulation of CD8-positive, alpha-beta T cell differentiation);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0045444(fat cell differentiation);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0046425(regulation of receptor signaling pathway via JAK-STAT);GO:0046426(negative regulation of receptor signaling pathway via JAK-STAT);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046854(phosphatidylinositol phosphorylation);GO:0046935(1-phosphatidylinositol-3-kinase regulator activity);GO:0050707(regulation of cytokine secretion);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0071230(cellular response to amino acid stimulus)",04120(Ubiquitin mediated proteolysis);04380(Osteoclast differentiation);04630(Jak-STAT signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04930(Type II diabetes mellitus);05145(Toxoplasmosis);05206(MicroRNAs in cancer),K04694,518795,ENSBTAT00000005753,NA,protein_coding,0.21,0.31,0.23,0.40,0.40,0.13,0,0,0,0.13
,,,,,,,,,,,,,,,,,,,,,,,,,,,
Others,ENSBTAG00000052988,miRNA,bta-mir-12036,bta-mir-12036 ,10.88,3.44,0.03,0.16,up,yes,NA,NA,NA,,ENSBTAT00000079993,NA,miRNA,0.68,0.36,1.10,1.78,0.94,0.35,0,0,0,0.10
Others,ENSBTAG00000049022,miRNA,bta-mir-12048,bta-mir-12048 ,19.08,4.25,0.00,0.04,up,yes,NA,NA,NA,,ENSBTAT00000073860,NA,miRNA,1.40,1.36,1.44,1.40,1.02,0,0,0,0,0.35
Others,ENSBTAG00000051527,miRNA,bta-mir-12055,bta-mir-12055 ,8093.90,12.98,0.03,0.13,up,yes,NA,NA,NA,,ENSBTAT00000076770,NA,miRNA,1.86,0,0.77,0.98,0.44,0,0,0,0,0
